Skip to Main Content

Paper Details

yippee like 3 (ypel3) is a novel gene required for myelinating and perineurial glia development.
PLoS Genet
10
2020
Cas9, Hypomyelination, Myelin basic protein, Schwann cell, YIPPEE LIKE 3, YPEL3, Ypel3, abnormal peripheral nerve conduction, areflexia, central and peripheral glial cell, cerebral hypomyelination, child, defasciculated peripheral nerves, early stop codon, genomic lesion, glial cells, hypertrophic peripheral nerves, hypomyelination, hypotonia, myelinating, neurological condition, neuropathy, novel gene, oligodendrocyte, oligodendrocyte precursor cells, open reading frame, patient, patients, perineurial cell, perineurial glia, perineurial glial precursors, yippee like 3, ypel3, ypel3 mutants, zebrafish, zebrafish mutants, zebrafish ypel3 mutants
Author NameAffiliation
Bernardo Blanco-SánchezInstitute of Neuroscience, University of Oregon
Aurélie ClémentInstitute of Neuroscience, University of Oregon
Jennifer E KylePacific Northwest National Laboratory
Jennifer E KylePacific Northwest National Laboratory
Jeremy WegnerInstitute of Neuroscience, University of Oregon
Jennifer B PhillipsInstitute of Neuroscience, University of Oregon
Ellen MacnamaraNational Institutes of Health Undiagnosed Diseases Program, National Institutes of Health
Ellen MacnamaraOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
David R AdamsNational Institutes of Health Undiagnosed Diseases Program, National Institutes of Health
David R AdamsOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
David R AdamsNational Institutes of Health Undiagnosed Diseases Program, National Institutes of Health
David R AdamsOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
Camilo ToroNational Institutes of Health Undiagnosed Diseases Program, National Institutes of Health
Camilo ToroOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
William A GahlNational Institutes of Health Undiagnosed Diseases Program, National Institutes of Health
William A GahlNational Human Genome Research Institute, National Institutes of Health
William A GahlNational Institutes of Health Undiagnosed Diseases Program, National Institutes of Health
William A GahlNational Human Genome Research Institute, National Institutes of Health
May Christine V MalicdanNational Institutes of Health Undiagnosed Diseases Program, National Institutes of Health
May Christine V MalicdanOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
May Christine V MalicdanNational Institutes of Health Undiagnosed Diseases Program, National Institutes of Health
May Christine V MalicdanOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
Cynthia J TifftNational Institutes of Health Undiagnosed Diseases Program, National Institutes of Health
Cynthia J TifftOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
Cynthia J TifftNational Institutes of Health Undiagnosed Diseases Program, National Institutes of Health
Cynthia J TifftOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
Erika M ZinkPacific Northwest National Laboratory
Erika M ZinkPacific Northwest National Laboratory
Kent J BloodsworthPacific Northwest National Laboratory
Kelly G StrattonPacific Northwest National Laboratory
Kelly G StrattonPacific Northwest National Laboratory
David M KoellerOregon Health and Science University
Thomas O MetzPacific Northwest National Laboratory
Monte WesterfieldInstitute of Neuroscience, University of Oregon
Monte WesterfieldInstitute of Neuroscience, University of Oregon
  • 1 - 35

Datasets

Release 1.2